Everforth Inc quarterly report, Q3 FY2021

Business context and reporting period

The supplied filing is ASGN Incorporated’s unaudited Form 10-Q for the quarter ended September 30, 2021; it does not identify Everforth Inc. as the registrant. ASGN provides technology and professional services through its Commercial and Federal Government segments. Unless noted, operating results below are continuing operations. The Oxford Global Resources business was sold on August 17, 2021, and is reported as discontinued operations.

Financial performance

MetricQ3 2021Q3 2020First nine months 2021First nine months 2020
Revenue$1,073.8 million$904.4 million$2,955.7 million$2,601.7 million
Gross profit / margin$308.7 million / 28.7%$236.3 million / 26.1%$828.7 million / 28.0%$706.4 million / 27.2%
Operating income$100.1 million$73.5 million$255.4 million$207.3 million
Income from continuing operations$66.3 million$46.7 million$166.4 million$129.3 million
Net income, including discontinued operations$212.0 million$52.3 million$324.9 million$144.9 million
Diluted EPS, continuing operations$1.24$0.88$3.10$2.44
  • Q3 revenue rose 18.7% year over year, including $42.0 million from acquisitions; excluding acquisition contributions, growth was 14.1%. Nine-month revenue rose 13.6%, or 11.4% excluding acquisitions.
  • Q3 Commercial revenue increased 25.8% to $774.9 million; Federal Government revenue increased 3.6% to $298.9 million. Nine-month growth was 14.8% and 10.5%, respectively.
  • Q3 gross margin expanded 2.6 percentage points, reflecting increased contribution from higher-margin Commercial services and changes in Federal Government contract mix. Nine-month margin expanded 0.8 percentage points.
  • Interest expense was $9.6 million in Q3 and $28.2 million for the first nine months. Nine-month effective tax rate was 26.8%.

Cash flow, liquidity and debt

  • Nine-month operating cash flow was $275.9 million, versus $337.8 million a year earlier. Management attributed the decline primarily to working-capital investment supporting growth and the end of CARES Act payroll-tax deferrals.
  • Investing cash flow was positive $249.2 million, including $499.1 million of proceeds from the Oxford sale; uses included $224.4 million for acquisitions and $25.6 million for capital expenditures. Financing cash flow was negative $119.4 million, mainly reflecting $118.4 million of share repurchases.
  • Cash and cash equivalents were $679.4 million at September 30, 2021, compared with $274.4 million at year-end 2020. Working capital was $831.2 million. The company reported full availability on its $250 million revolving credit facility and said available cash, expected operating cash flow and revolver capacity should cover obligations and needs for the next 12 months.
  • Long-term debt was $1,033.5 million: $490.8 million under the term loan and $550 million of senior notes, net of deferred loan costs. There were no revolver borrowings; the company reported covenant compliance. The notes carry a 4.625% coupon and mature in 2028. The term loan bears a variable rate; management estimated a 100-basis-point rate increase would change annual interest expense by about $4.9 million.

Material changes, outlook and risks

  • The Oxford business was sold for $525.0 million, producing a $218.6 million pretax gain ($149.3 million after tax). The associated income taxes of $111.7 million were due December 15, 2021. Reported net income and EPS therefore include a substantial one-time disposal gain; continuing-operations results better reflect ongoing performance.
  • ASGN acquired three consulting-services businesses for $221.3 million in cash during the first nine months. Potential contingent consideration was up to $34.0 million, of which $15.3 million was accrued at quarter-end. Purchase-price allocations for some acquisitions were not final.
  • Federal Government contract backlog was $3,133.4 million, including $558.3 million funded. Q3 book-to-bill was 1.4-to-1; trailing-twelve-month book-to-bill was 1.1-to-1. Backlog estimates are subject to contract awards, funding, extensions, protests and termination or completion of contracts.
  • The company provided no specific financial guidance in the supplied filing. Management cited broad Commercial growth and segment margin expansion; it also cautioned that forward-looking statements are subject to risks, including those related to the Oxford divestiture, and that past performance is not necessarily indicative of future results.
  • Management reported effective disclosure controls and no material changes in internal control over financial reporting. It reported no material changes to previously disclosed risk factors or commitments. Ordinary-course legal matters were not expected to have a material financial effect.

Important facts for investors to verify

  • Confirm the issuer identity: the supplied filing is for ASGN Incorporated, not Everforth Inc.
  • Separate ongoing earnings from the Oxford divestiture gain when assessing year-over-year net income and EPS.
  • Review the timing and payment of the $111.7 million sale-related tax liability and the use of sale proceeds for acquisitions or other capital allocation.
  • Monitor organic growth, Commercial consulting performance, Federal Government contract funding and backlog conversion, and whether margin expansion persists.
  • Assess acquisition integration, contingent consideration and final purchase-price allocations, alongside variable-rate debt exposure and share repurchases.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.